within Pharmacolibrary.Drugs.ATC.G;

model G03XB02
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.62,
    Cl             = 0.001,
    adminDuration  = 600,
    adminMass      = 30 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 1.0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.004333333333333333,
    Tlag           = 600,            
    Vdp             = 0.395,
    k12             = 32,
    k21             = 32
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G03XB02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ulipristal acetate is a selective progesterone receptor modulator (SPRM) used primarily as an emergency contraceptive in women and for the treatment of uterine fibroids. It is approved in numerous countries for these uses, but its indication for uterine fibroids has faced restrictions or suspensions in some regions due to concerns regarding liver toxicity.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters observed in adult healthy female volunteers receiving a single oral dose of 30 mg ulipristal acetate.</p><h4>References</h4><ol><li><p>Pohl, O, et al., &amp; Gotteland, JP (2015). The clinical pharmacology and pharmacokinetics of ulipristal acetate for the treatment of uterine fibroids. <i>Reproductive sciences (Thousand Oaks, Calif.)</i> 22(4) 476–483. DOI:<a href=&quot;https://doi.org/10.1177/1933719114549850&quot;>10.1177/1933719114549850</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25228633/&quot;>https://pubmed.ncbi.nlm.nih.gov/25228633</a></p></li><li><p>Pohl, O, et al., &amp; Gotteland, JP (2013). Effects of erythromycin at steady-state concentrations on the pharmacokinetics of ulipristal acetate. <i>Journal of clinical pharmacy and therapeutics</i> 38(6) 512–517. DOI:<a href=&quot;https://doi.org/10.1111/jcpt.12098&quot;>10.1111/jcpt.12098</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/24102384/&quot;>https://pubmed.ncbi.nlm.nih.gov/24102384</a></p></li><li><p>Martinez, AM, &amp; Thomas, MA (2012). Ulipristal acetate as an emergency contraceptive agent. <i>Expert opinion on pharmacotherapy</i> 13(13) 1937–1942. DOI:<a href=&quot;https://doi.org/10.1517/14656566.2012.705832&quot;>10.1517/14656566.2012.705832</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22770536/&quot;>https://pubmed.ncbi.nlm.nih.gov/22770536</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G03XB02;
